Scientific Sessions 2024  /  The Future of Lipid Management: Using Lessons From Our Past  /  The Evolution from Statins to Monoclonal Antibodies and Antisense Technology for Lipid Lowering
Logo

American Heart Association

  2
  0

Final ID:

The Evolution from Statins to Monoclonal Antibodies and Antisense Technology for Lipid Lowering

  • Michos, Erin  ( Johns Hopkins , Baltimore , Maryland , United States )
  • Crooke, Rosanne  ( Ionis Pharmaceuticals , Carlsbad , California , United States )
  • Shapiro, Michael  ( Wake Forest Univ School of Medicine , Winston Salem , North Carolina , United States )
    • Author Disclosures:
    Erin Michos: DO have relevant financial relationships ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Zoll:Past (completed) ; Consultant:Arrowhead:Active (exists now) ; Consultant:Novartis:Past (completed) ; Consultant:Amgen:Past (completed) ; Consultant:AstraZeneca:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Edwards Lifescience:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:Esperion:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) | Rosanne Crooke: DO NOT have relevant financial relationships | Michael Shapiro: DO have relevant financial relationships ; Consultant:Amgen:Active (exists now) ; Advisor:Arrowhead:Active (exists now) ; Advisor:Merck:Active (exists now) ; Consultant:Regeneron:Active (exists now) ; Advisor:Ionis:Active (exists now) ; Advisor:Agepha:Past (completed) ; Consultant:Novartis:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

The Future of Lipid Management: Using Lessons From Our Past

Saturday, 11/16/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
The Discovery of the LDL-Receptor and It's Potential as a Target

Goldstein Joseph, Brown Michael, Ballantyne Christie

How Low and How Fast Should We Go with LDL-Cholesterol?

Ray Kausik, Lloyd-jones Donald, Tokgozoglu Lale

More abstracts from these authors:
Discussant: PALISADE

Shapiro Michael

Lipoprotein (a), Triglyceride-Glucose Index and Incident Atherosclerotic Cardiovascular Disease (ASCVD): Analysis of the UK Biobank

Kazibwe Richard, Bhatia Harpreet, Michos Erin, Shapiro Michael, Schaich Christopher, Chevli Parag, Kingsley Jeffrey, Rikhi Rishi, Ahmad Muhammad, Mirzai Saeid, Namutebi Juliana, Mehta Anurag

You have to be authorized to contact abstract author. Please, Login
Not Available